Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum
Open Access
- 1 December 2020
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Psychopharmacology
Abstract
Background: Protracted withdrawal syndrome (PWS) after stopping antidepressants (frequently also referred to as post-acute withdrawal syndrome or PAWS) has been described in a few case reports. However, a detailed quantitative analysis of specific symptom manifestations in antidepressant PWS is still lacking. Methods: We extracted patient narratives from a large English-language internet forum , a peer support site concerned about withdrawal from antidepressants. PWS was ascertained based on diagnostic criteria proposed by Chouinard and Chouinard, specifically > 6 months of continuous antidepressant use, with emergence of new and/or more intense symptoms after discontinuation that last beyond the initial 6 weeks of acute withdrawal. We assessed medication history, outcome of PWS, and the prevalence of specific symptoms. Results: In total, n = 69 individual reports of protracted withdrawal were selected for analysis. At time of the subjects' most recent reports, duration of PWS ranged from 5 to 166 months, mean = 37 months, median = 26 months. Length of time on the antidepressant causing protracted withdrawal ranged from 6 to 278 months, mean = 96 months, and median = 79 months. Throughout the withdrawal experience, affective symptoms, mostly anxiety, depression, emerging suicidality and agitation, were reported by 81%. Somatic symptoms, mostly headache, fatigue, dizziness, brain zaps, visual changes, muscle aches, tremor, diarrhea, and nausea were reported by 75%. Sleep problems (44%) and cognitive impairments (32%) were mentioned less frequently. These broad symptom domains were largely uncorrelated. Conclusion: PWS or PAWS from antidepressants can be severe and long-lasting, and its manifestations clinically heterogeneous. Long-term antidepressant exposure may cause multiple body system impairments. Although both somatic and affective symptoms are frequent, they are mostly unrelated in terms of occurrence. Proper recognition and detection of PWS thus requires a comprehensive assessment of medication history, duration of the withdrawal syndrome, and its various somatic, affective, sleep, and cognitive symptoms.Keywords
Funding Information
- Stefan Hearst (na)
This publication has 67 references indexed in Scilit:
- Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms InvolvedFrontiers in Pharmacology, 2013
- What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re‐uptake inhibitorsAddiction, 2012
- Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than GoodFrontiers in Psychology, 2012
- The mechanisms of tolerance in antidepressant actionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- REVIEW: Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?Addiction Biology, 2010
- Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substancesMedical Hypotheses, 2009
- Autonomy of Autonomic Dysfunction in Major DepressionPsychosomatic Medicine, 2009
- Emotional side-effects of selective serotonin reuptake inhibitors: qualitative studyThe British Journal of Psychiatry, 2009
- Patients' concerns about and problems experienced with discontinuation of antidepressantsInternational Journal of Pharmacy Practice, 2007
- Recognising and managing antidepressant discontinuation symptomsAdvances in Psychiatric Treatment, 2007